Hideyuki Hayashi

2.8k total citations
93 papers, 1.9k citations indexed

About

Hideyuki Hayashi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hideyuki Hayashi has authored 93 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Hideyuki Hayashi's work include Cancer Genomics and Diagnostics (20 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Genetic factors in colorectal cancer (9 papers). Hideyuki Hayashi is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Genetic factors in colorectal cancer (9 papers). Hideyuki Hayashi collaborates with scholars based in Japan, United States and Germany. Hideyuki Hayashi's co-authors include Ken Hayashi, Fumihiko Hayashi, Fuminori Nakao, Kenji Oshima, Jay S. Pepose, Serge de Bustros, Bert M. Glaser, Janice A. Jerdan, Mikaël Sébag and Ronald G. Michels and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemistry.

In The Last Decade

Hideyuki Hayashi

90 papers receiving 1.8k citations

Peers

Hideyuki Hayashi
Mandeep S. Sagoo United Kingdom
Marcus C. de Jong Netherlands
Yosuf El‐Shabrawi Austria
Nikolaos E. Bechrakis Germany
Qing Lü China
Akihiro Kaneko Japan
Lu Xu United States
Robert S. Malyapa United States
Ami B. Patel United States
Robert M. Conway Australia
Mandeep S. Sagoo United Kingdom
Hideyuki Hayashi
Citations per year, relative to Hideyuki Hayashi Hideyuki Hayashi (= 1×) peers Mandeep S. Sagoo

Countries citing papers authored by Hideyuki Hayashi

Since Specialization
Citations

This map shows the geographic impact of Hideyuki Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Hayashi more than expected).

Fields of papers citing papers by Hideyuki Hayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Hayashi. The network helps show where Hideyuki Hayashi may publish in the future.

Co-authorship network of co-authors of Hideyuki Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Hayashi. A scholar is included among the top collaborators of Hideyuki Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Hayashi. Hideyuki Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Kohei, Ryutaro Kawano, Eriko Aimono, et al.. (2024). Characterizing multi‐PIK3CA mutations across cancer types: Toward precision oncology. Cancer Medicine. 13(14). e70052–e70052. 4 indexed citations
2.
Kawasaki, Kenta, Hideyuki Hayashi, S. Shimizu, et al.. (2024). Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia. Oncology Letters. 28(6). 568–568. 1 indexed citations
3.
Kage, Hidenori, Katsutoshi Oda, Manabu Muto, et al.. (2023). Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan. Cancer Science. 114(7). 3041–3049. 7 indexed citations
4.
Tahara, Makoto, Tatsunori Shimoi, Satoshi Nishiwaki, et al.. (2023). Phase II trial of dabrafenib and trametinib in patients with BRAFV600E/R or non-BRAFV600 mutated advanced solid tumors: Results from the BELIEVE trial (NCCH1901).. Journal of Clinical Oncology. 41(16_suppl). 3096–3096. 1 indexed citations
5.
Hayashi, Hideyuki, Kei Kunimasa, Shigeki Tanishima, et al.. (2023). Germline BRCA2 variant with low variant allele frequency detected in tumor‐only comprehensive genomic profiling. Cancer Science. 115(2). 682–686. 5 indexed citations
6.
Shimozaki, Keitaro, Yasutaka Sukawa, Yasunori Sato, et al.. (2021). Analysis of Risk Factors for Immune-Related Adverse Events in Various Solid Tumors Using Real-World Data. Future Oncology. 17(20). 2593–2603. 16 indexed citations
7.
Shimozaki, Keitaro, Kenro Hirata, Yukie Hayashi, et al.. (2021). The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study. Diagnostics. 11(3). 543–543. 2 indexed citations
8.
Iwasaki, Eisuke, Seiichiro Fukuhara, Masayasu Horibe, et al.. (2021). Endoscopic Ultrasound-Guided Sampling for Personalized Pancreatic Cancer Treatment. Diagnostics. 11(3). 469–469. 6 indexed citations
9.
Shimozaki, Keitaro, Yasutaka Sukawa, Isao Kurihara, et al.. (2020). <p>Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors</p>. Cancer Management and Research. Volume 12. 4585–4593. 57 indexed citations
10.
Hayashi, Hideyuki, et al.. (2019). Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma. Medical Oncology. 37(1). 10–10. 2 indexed citations
11.
Todaka, Akiko, Nobumasa Mizuno, Masato Ozaka, et al.. (2018). Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan. Pancreas. 47(5). 631–636. 13 indexed citations
12.
Hayashi, Hideyuki, Shigeki Tanishima, Kyōkō Fujii, et al.. (2018). Genomic testing for pancreatic cancer in clinical practice as real-world evidence. Pancreatology. 18(6). 647–654. 27 indexed citations
13.
Hayashi, Hideyuki, Kazuto Ashizawa, Akifumi Nishida, et al.. (2017). Comparison between solid component size on thin-section CT and pathologic lymph node metastasis and local invasion in T1 lung adenocarcinoma. Japanese Journal of Radiology. 35(3). 109–115. 7 indexed citations
14.
Sasaki, Mitsuhito, Hironori Ueno, Katsuhiro Omae, et al.. (2017). Risk factors for febrile neutropenia (FN) in unresectable/recurrent pancreatic cancer(PC) patients(pts) receiving FOLFIRINOX (FFX) from JASPAC06 study. Annals of Oncology. 28. v260–v260. 2 indexed citations
15.
Matsumoto, Keitaro, Naoya Yamasaki, Tomoshi Tsuchiya, et al.. (2012). Three-Dimensional Computed Tomography for a Mediastinal Basal Pulmonary Artery. The Annals of Thoracic Surgery. 94(5). e115–e116. 19 indexed citations
16.
Hayashi, Hideyuki, Ichiro Sakamoto, Ichiro Isomoto, et al.. (2011). Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA. Abdominal Imaging. 37(2). 239–243. 11 indexed citations
17.
Nanashima, Atsushi, Syuuichi Tobinaga, Takafumi Abo, et al.. (2010). Usefulness of measuring hepatic functional volume using technetium-99m galactosyl serum albumin scintigraphy in hilar bile duct carcinoma. Clinical Journal of Gastroenterology. 3(3). 174–178. 2 indexed citations
18.
Hayashi, Ken, et al.. (2010). Optimal Amount of Anisometropia for Pseudophakic Monovision. Journal of Refractive Surgery. 27(5). 332–338. 35 indexed citations
19.
Hayashi, Hideyuki, et al.. (2004). Achievement of Reactor-Outlet Coolant Temperature of 950°C in HTTR. Journal of Nuclear Science and Technology. 41(12). 1245–1254. 91 indexed citations
20.
Hayashi, Ken, Hideyuki Hayashi, Fuminori Nakao, & Fumihiko Hayashi. (2001). Changes in posterior capsule opacification after poly(methyl methacrylate), silicone, and acrylic intraocular lens implantation. Journal of Cataract & Refractive Surgery. 27(6). 817–824. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mandeep S. Sagoo Breakdown of academic impact, for papers by Marcus C. de Jong Breakdown of academic impact, for papers by Yosuf El‐Shabrawi Breakdown of academic impact, for papers by Nikolaos E. Bechrakis Breakdown of academic impact, for papers by Qing Lü Breakdown of academic impact, for papers by Akihiro Kaneko Breakdown of academic impact, for papers by Lu Xu Breakdown of academic impact, for papers by Robert S. Malyapa Breakdown of academic impact, for papers by Ami B. Patel Breakdown of academic impact, for papers by Robert M. Conway
Rankless by CCL
2026